. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Child, PreschoolDrug ApprovalEnzyme Activators/therapeutic useHumansIduronate Sulfatase/adverse effectsIduronate Sulfatase/therapeutic useInfantMucopolysaccharidosis II/drug therapyOrphan Drug ProductionRare Diseases/drug therapyUnited StatesUnited States Food and Drug Administration
Substances: See more » Enzyme ActivatorsIduronate Sulfataseidursulfase
Year: 2006 PMID: 17333554
Source DB: PubMed Journal: FDA Consum ISSN: 0362-1332